Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00925704 · ClinicalTrials.gov registry record · Phase 1
The Pharmacokinetics of Rocaltrol When Administered Alone or in Combination With Fosrenol or Renvela in Healthy Volunteers
A Phase 1 study, sponsored by Shire.
- Completed
- Registry status
- Phase 1
- Development phase
- 41
- Enrollment target
NCT00925704 is a Phase 1 study that has completed, run by Shire. The registered enrollment target is 41 participants.
The verdict
NCT00925704, a Phase 1 study, has completed, sponsored by Shire.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 41 participants
- Enrollment target
Study Summary
To assess the effects of lanthanum carbonate (FOSRENOL) or sevelamer carbonate (RENVELA) on the pharmacokinetics of oral calcitriol (ROCALTROL)
Interventions
- DRUG Calcitriol
- DRUG Lanthanum carbonate + Calcitriol
- DRUG Sevelamer carbonate + Calcitriol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2009-06-01 |
| Est. Completion | 2009-07-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00925704
The ClinicalTrials.gov registry entry for NCT00925704 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shire, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Calcitriol is the first listed.
NCT00925704 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00925704 about?
NCT00925704 is a clinical study titled "The Pharmacokinetics of Rocaltrol When Administered Alone or in Combination With Fosrenol or Renvela in Healthy Volunteers". To assess the effects of lanthanum carbonate (FOSRENOL) or sevelamer carbonate (RENVELA) on the pharmacokinetics of oral calcitriol (ROCALTROL)
What is the current status of trial NCT00925704?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 41 participants. The study started on 2009-06-01. Estimated completion is 2009-07-31.
What interventions are being tested in trial NCT00925704?
The interventions under investigation include: Calcitriol (DRUG), Lanthanum carbonate + Calcitriol (DRUG), Sevelamer carbonate + Calcitriol (DRUG).
Who is sponsoring clinical trial NCT00925704?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.